Evidence map›Paper›PMID 21612477›Full record

ArticleThe New England journal of medicine2011

Bending the cost curve in cancer care.

Thomas J Smith, Bruce E Hillner

Registry-linked trialAbstract read
In one paragraph

Article in The New England journal of medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02261051 (Symptom Management, Quality of Life and Satisfaction With Care for Advanced Stage Cancers - Control Arm), which is not on this map. Cited by 137 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02261051 withdrawnnot on this mapstarted 2014, after this paper: background citation

Symptom Management, Quality of Life and Satisfaction With Care for Advanced Stage Cancers - Control Arm

TypeobservationalSponsorLancaster General HospitalRan2014 to 2015Enrolled0ConditionsCancer, Advanced CancerArmsStandard of care
3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Cost and Cost-Effectiveness of Treating Human Epidermal Growth Factor Receptor 2-Low Metastatic Breast Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Thomas J SmithDivision of Hematology-Oncology and Palliative Care, and Massey Cancer Center, Virginia Commonwealth University, Richmond, USA.
Bruce E Hillner

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rosalie Wollett · 1985 to 2026
$208.6M
NCI NIH HHS P30 CA006973
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Health Care CostsPractice Guidelines as TopicAntineoplastic AgentsAttitude of Health PersonnelCost ControlHealth Services MisuseHumansMedical OncologyNeoplasmsPalliative CarePractice Patterns, Physicians'Societies, MedicalUnited StatesAntineoplastic Agents

Identifiers

PMID21612477
PMCPMC4042405

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.